Mai Capital Management Teva Pharmaceutical Industries LTD Transaction History

Mai Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 12, 2018	SELL	$21.06 - $25.65 $176,735 - $215,254	-8,392 Closed	0 $0
Q2 2018 Aug 16, 2018	BUY	$16.77 - $24.71 $140,733 - $207,366	8,392 New	8,392 $204,000
Q3 2017 Oct 12, 2017	SELL	$15.41 - $32.17 $275,900 - $575,971	-17,904 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	17,904	17,904 $595,000

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

Stay updated on Mai Capital Management with notifications on news.